SOL Global Investments Corp. (CNSX: SOL)
Health Care · Pharmaceuticals · CA
CA$—
— today · — 1Y
SOL Global Investments Corp. (CNSX: SOL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $764.92K and employs 5 people.
trading between 0.03 and 1.60.
Tweenvest scores SOL Global Investments Corp. across four factors: quality 41/100, value 48/100. Its strongest factor is value.
SOL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $764.92K
- Revenue (TTM)
- $-13.08M
- P/E
- —
- EPS
- -4.45
- Dividend yield
- —
- Beta (5Y)
- 1.70
- 52-week high
- CA$1.60
- 52-week low
- CA$0.03
- Avg volume (3M)
- —
- Shares outstanding
- 26.61M
- Employees
- 5
- Next earnings
- —
About SOL Global Investments Corp.
SOL Global Investments Corp. functions as a private equity firm dedicated to supplying expansion capital to small and mid-sized enterprises. The company primarily channels its investments into a variety of growing sectors, such as the U.S. cannabis market, cannabidiol (CBD) products, the health and wellness industry, competitive gaming (E-sports), and electric transportation solutions. While its headquarters are situated in Toronto, Canada, SOL Global Investments Corp. also operates an office in Miami Beach, Florida.
- ISIN
- CA78471G4079
- Listed since
- Nov 14, 2012
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.